PriceTargets.com logo

Immunodiagnostic Systems - IDH Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0 As of 07/13/2021 12:59 AM ET
+0 (0.00%)

This chart shows the closing price for IDH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Immunodiagnostic Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IDH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IDH

Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for Immunodiagnostic Systems in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.

This chart shows the closing price for IDH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Immunodiagnostic Systems. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/21/2019Peel HuntReiterated RatingUnder Review
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Immunodiagnostic Systems logo
Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. The company provides its products and services for diagnosis of bone metabolism, calcium metabolism, hypertension, chronic kidney disease mineral bone disorder, growth, fertility, autoimmunity, infectious disease, sarcoidosis, and allergy. Immunodiagnostic Systems Holdings PLC was founded in 1977 and is headquartered in Boldon, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 378
Low: 378
High: 378

52 Week Range

Now: N/A

Volume

N/A

Average Volume

14,539 shs

Market Capitalization

£108.80 million

P/E Ratio

290.77

Dividend Yield

0.50%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Immunodiagnostic Systems?

The following Wall Street research analysts have issued reports on Immunodiagnostic Systems in the last year:
View the latest analyst ratings for IDH.

What is the current price target for Immunodiagnostic Systems?

0 Wall Street analysts have set twelve-month price targets for Immunodiagnostic Systems in the last year. has the lowest price target set, forecasting a price of £100,000 for Immunodiagnostic Systems in the next year.
View the latest price targets for IDH.

What is the current consensus analyst rating for Immunodiagnostic Systems?

Immunodiagnostic Systems currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for IDH.

What other companies compete with Immunodiagnostic Systems?

Other companies that are similar to Immunodiagnostic Systems include Intelligent Ultrasound Group plc (MED.L), Futura Medical, Verseon, Tiziana Life Sciences and Kooth. Learn More about companies similar to Immunodiagnostic Systems.

How do I contact Immunodiagnostic Systems' investor relations team?

Immunodiagnostic Systems' physical mailing address is 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom. The company's listed phone number is +44-191-5190660. The official website for Immunodiagnostic Systems is www.idsplc.com. Learn More about contacing Immunodiagnostic Systems investor relations.